Raphaël MetropDirector, Transaction Advisory

    Raphaël Metrop

    Director, Transaction Advisory

    Raphaël Metrop, PharmD, has international experience in corporate and business development, mainly acquired in a start-up environment in direct contact with CEOs and Board Members.

    As the Corporate Business Development Manager of Imaxio, now known as Osivax, he had the chance to work on a wide range of projects in the field of immunology, including acquisition and divestment operations, in and out-licensing deals, submission of grant applications, creation of public-private consortiums, management of R&D programs and monitoring of patent portfolios. Before joining Alira Health in October 2018, Raphaël was Head of Corporate Business Development of Fab’entech, and had simultaneously founded a small consulting company providing services to a French family office.

    Raphaël graduated from the University of Lyon, France, with a Pharmaceutical Doctorate, and from the IMIS Institute, France, with a Masters Degree in marketing and management. He has also been granted in 2016 with an International Certificate in Corporate Finance from HEC Paris, France.

    John Brooks III, Partner, Boston, MA, USA